HEADER DE NOVO PROTEIN 01-AUG-23 8TND TITLE DE NOVO DESIGNED PROTEIN BINDS POLY ADP RIBOSE POLYMERASE INHIBITORS TITLE 2 (PARPI) - HOLO VELIPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: DE NOVO DESIGNED PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS DRUG BINDING, 4-HELIX BUNDLE, DE NOVO DESIGN, PARPI, DE NOVO PROTEIN, KEYWDS 2 VELIPARIB EXPDTA X-RAY DIFFRACTION AUTHOR L.LU,W.F.DEGRADO REVDAT 1 24-APR-24 8TND 0 JRNL AUTH L.LU,X.GOU,S.K.TAN,S.I.MANN,H.YANG,X.ZHONG,D.GAZGALIS, JRNL AUTH 2 J.VALDIVIEZO,H.JO,Y.WU,M.E.DIOLAITI,A.ASHWORTH,N.F.POLIZZI, JRNL AUTH 3 W.F.DEGRADO JRNL TITL DE NOVO DESIGN OF DRUG-BINDING PROTEINS WITH PREDICTABLE JRNL TITL 2 BINDING ENERGY AND SPECIFICITY. JRNL REF SCIENCE V. 384 106 2024 JRNL REFN ESSN 1095-9203 JRNL PMID 38574125 JRNL DOI 10.1126/SCIENCE.ADL5364 REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 123616 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.620 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 78.5900 - 3.1000 1.00 9347 154 0.1879 0.1981 REMARK 3 2 3.1000 - 2.4600 1.00 8909 147 0.1842 0.2124 REMARK 3 3 2.4600 - 2.1500 1.00 8813 144 0.1694 0.1983 REMARK 3 4 2.1500 - 1.9600 1.00 8787 145 0.1878 0.1974 REMARK 3 5 1.9600 - 1.8200 1.00 8688 142 0.1967 0.2190 REMARK 3 6 1.8200 - 1.7100 1.00 8693 144 0.2033 0.2431 REMARK 3 7 1.7100 - 1.6200 1.00 8663 142 0.2402 0.2716 REMARK 3 8 1.6200 - 1.5500 1.00 8684 143 0.2428 0.2864 REMARK 3 9 1.5500 - 1.4900 1.00 8620 142 0.2319 0.2326 REMARK 3 10 1.4900 - 1.4400 1.00 8588 139 0.2280 0.2421 REMARK 3 11 1.4400 - 1.4000 1.00 8605 142 0.2793 0.3482 REMARK 3 12 1.4000 - 1.3600 1.00 8625 142 0.3415 0.3881 REMARK 3 13 1.3600 - 1.3200 1.00 8607 141 0.4193 0.4842 REMARK 3 14 1.3200 - 1.2900 0.93 7989 131 0.4710 0.5265 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.229 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.551 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3525 REMARK 3 ANGLE : 0.924 4782 REMARK 3 CHIRALITY : 0.050 561 REMARK 3 PLANARITY : 0.007 618 REMARK 3 DIHEDRAL : 7.221 477 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TND COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1000276302. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : POINTLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 123927 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.290 REMARK 200 RESOLUTION RANGE LOW (A) : 202.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 67.60 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 31.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.31 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M AMMONIUM SULFATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.45100 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 134.90200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 101.17650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 168.62750 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.72550 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 67.45100 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 134.90200 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 168.62750 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 101.17650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 33.72550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 367 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 416 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 408 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 383 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 418 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 430 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 442 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH11 ARG A 39 OD2 ASP A 42 1.57 REMARK 500 O HOH C 335 O HOH C 392 1.73 REMARK 500 O HOH B 323 O HOH B 440 1.90 REMARK 500 O HOH B 379 O HOH C 336 1.92 REMARK 500 O HOH A 406 O HOH A 458 1.94 REMARK 500 O HOH A 322 O HOH A 368 2.00 REMARK 500 O HOH B 405 O HOH B 456 2.00 REMARK 500 O HOH C 401 O HOH C 421 2.03 REMARK 500 O HOH C 301 O HOH C 304 2.06 REMARK 500 O HOH B 400 O HOH B 451 2.10 REMARK 500 OH TYR C 35 O HOH C 301 2.10 REMARK 500 OD2 ASP B 29 O HOH B 301 2.10 REMARK 500 O HOH B 443 O HOH B 466 2.10 REMARK 500 O HOH A 425 O HOH A 450 2.13 REMARK 500 O HOH C 372 O HOH C 377 2.13 REMARK 500 O HOH A 451 O HOH B 445 2.15 REMARK 500 OD2 ASP A 81 O HOH A 301 2.15 REMARK 500 O HOH C 373 O HOH C 375 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 428 O HOH B 313 8555 1.95 REMARK 500 O HOH B 407 O HOH B 410 8555 1.97 REMARK 500 O HOH B 321 O HOH C 302 3664 2.03 REMARK 500 O HOH A 390 O HOH C 390 5564 2.13 REMARK 500 O HOH A 360 O HOH B 433 8555 2.14 REMARK 500 O HOH A 429 O HOH B 424 8555 2.14 REMARK 500 O HOH B 418 O HOH B 418 8555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 2 -35.19 -169.81 REMARK 500 LYS B 146 -67.68 45.64 REMARK 500 ASP C 77 119.87 -178.39 REMARK 500 LYS C 146 105.20 114.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TND A 1 147 PDB 8TND 8TND 1 147 DBREF 8TND B 1 147 PDB 8TND 8TND 1 147 DBREF 8TND C 1 147 PDB 8TND 8TND 1 147 SEQRES 1 A 147 SER ASP ALA GLN GLU ILE LEU SER ARG LEU ASN SER VAL SEQRES 2 A 147 LEU GLU ALA ALA TRP LYS THR ILE LEU ASN LEU ALA SER SEQRES 3 A 147 ALA THR ASP ALA ALA GLU LYS ALA TYR LYS GLU GLY ARG SEQRES 4 A 147 GLU GLU ASP LEU ALA THR TYR LEU ASP GLN ALA ALA SER SEQRES 5 A 147 TYR GLN SER GLN VAL ASP GLN TYR ALA VAL GLU THR VAL SEQRES 6 A 147 ARG LEU LEU ALA GLU LEU LYS LYS VAL PHE PRO ASP GLU SEQRES 7 A 147 GLU ALA ASP ARG ALA LEU GLN ILE ALA GLU LYS LEU LEU SEQRES 8 A 147 LYS THR VAL GLN GLU ALA SER LYS THR LEU ASP THR ALA SEQRES 9 A 147 VAL ALA ALA ALA ALA ASN GLY ASP GLU GLU THR PHE ALA SEQRES 10 A 147 LYS ALA PHE ASN GLN PHE VAL SER LEU GLY ASN GLN ALA SEQRES 11 A 147 ASP THR LEU PHE THR GLN LEU GLN ARG THR LEU THR ASN SEQRES 12 A 147 LEU ASN LYS LYS SEQRES 1 B 147 SER ASP ALA GLN GLU ILE LEU SER ARG LEU ASN SER VAL SEQRES 2 B 147 LEU GLU ALA ALA TRP LYS THR ILE LEU ASN LEU ALA SER SEQRES 3 B 147 ALA THR ASP ALA ALA GLU LYS ALA TYR LYS GLU GLY ARG SEQRES 4 B 147 GLU GLU ASP LEU ALA THR TYR LEU ASP GLN ALA ALA SER SEQRES 5 B 147 TYR GLN SER GLN VAL ASP GLN TYR ALA VAL GLU THR VAL SEQRES 6 B 147 ARG LEU LEU ALA GLU LEU LYS LYS VAL PHE PRO ASP GLU SEQRES 7 B 147 GLU ALA ASP ARG ALA LEU GLN ILE ALA GLU LYS LEU LEU SEQRES 8 B 147 LYS THR VAL GLN GLU ALA SER LYS THR LEU ASP THR ALA SEQRES 9 B 147 VAL ALA ALA ALA ALA ASN GLY ASP GLU GLU THR PHE ALA SEQRES 10 B 147 LYS ALA PHE ASN GLN PHE VAL SER LEU GLY ASN GLN ALA SEQRES 11 B 147 ASP THR LEU PHE THR GLN LEU GLN ARG THR LEU THR ASN SEQRES 12 B 147 LEU ASN LYS LYS SEQRES 1 C 147 SER ASP ALA GLN GLU ILE LEU SER ARG LEU ASN SER VAL SEQRES 2 C 147 LEU GLU ALA ALA TRP LYS THR ILE LEU ASN LEU ALA SER SEQRES 3 C 147 ALA THR ASP ALA ALA GLU LYS ALA TYR LYS GLU GLY ARG SEQRES 4 C 147 GLU GLU ASP LEU ALA THR TYR LEU ASP GLN ALA ALA SER SEQRES 5 C 147 TYR GLN SER GLN VAL ASP GLN TYR ALA VAL GLU THR VAL SEQRES 6 C 147 ARG LEU LEU ALA GLU LEU LYS LYS VAL PHE PRO ASP GLU SEQRES 7 C 147 GLU ALA ASP ARG ALA LEU GLN ILE ALA GLU LYS LEU LEU SEQRES 8 C 147 LYS THR VAL GLN GLU ALA SER LYS THR LEU ASP THR ALA SEQRES 9 C 147 VAL ALA ALA ALA ALA ASN GLY ASP GLU GLU THR PHE ALA SEQRES 10 C 147 LYS ALA PHE ASN GLN PHE VAL SER LEU GLY ASN GLN ALA SEQRES 11 C 147 ASP THR LEU PHE THR GLN LEU GLN ARG THR LEU THR ASN SEQRES 12 C 147 LEU ASN LYS LYS HET 78P A 201 35 HET SO4 A 202 5 HET 78P B 201 35 HET SO4 B 202 5 HET 78P C 201 35 HET SO4 C 202 5 HETNAM 78P (2R)-2-(7-CARBAMOYL-1H-BENZIMIDAZOL-2-YL)-2- HETNAM 2 78P METHYLPYRROLIDINIUM HETNAM SO4 SULFATE ION HETSYN 78P VELIPARIB FORMUL 4 78P 3(C13 H16 N4 O) FORMUL 5 SO4 3(O4 S 2-) FORMUL 10 HOH *475(H2 O) HELIX 1 AA1 ASP A 2 GLY A 38 1 37 HELIX 2 AA2 ARG A 39 PHE A 75 1 37 HELIX 3 AA3 ASP A 77 GLY A 111 1 35 HELIX 4 AA4 ASP A 112 LYS A 146 1 35 HELIX 5 AA5 ASP B 2 GLY B 38 1 37 HELIX 6 AA6 ARG B 39 PHE B 75 1 37 HELIX 7 AA7 ALA B 80 GLY B 111 1 32 HELIX 8 AA8 ASP B 112 LYS B 146 1 35 HELIX 9 AA9 ASP C 2 GLY C 38 1 37 HELIX 10 AB1 ARG C 39 PHE C 75 1 37 HELIX 11 AB2 ASP C 77 GLY C 111 1 35 HELIX 12 AB3 ASP C 112 ASN C 145 1 34 CRYST1 90.750 90.750 202.353 90.00 90.00 120.00 P 61 2 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011019 0.006362 0.000000 0.00000 SCALE2 0.000000 0.012724 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004942 0.00000